We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAA icon
526
Mid-America Apartment Communities
MAA
$15.8B
$1.47M 0.01%
9,261
– –
EG icon
527
Everest Group
EG
$15.8B
$1.47M 0.01%
3,754
-149
-4% -$56.8K
NDSN icon
528
Nordson
NDSN
$16.9B
$1.45M 0.01%
5,526
+750
+16% +$183K
NTAP icon
529
NetApp
NTAP
$34.2B
$1.44M 0.01%
11,696
-840
-7% -$105K
MSTR icon
530
Strategy Inc
MSTR
$35.1B
$1.43M 0.01%
8,492
+142
+2% +$20.3K
JBTM
531
JBT Marel
JBTM
$7.59B
$1.41M 0.01%
14,325
– –
AVTR icon
532
Avantor
AVTR
$8.48B
$1.38M 0.01%
53,198
-4,226
-7% -$104K
CTLT
533
DELISTED
CATALENT, INC.
CTLT
$1.36M 0.01%
22,412
+6,773
+43% +$401K
WBD icon
534
Warner Bros
WBD
$64.2B
$1.36M 0.01%
164,476
– –
EQT icon
535
EQT Corp
EQT
$32.3B
$1.36M 0.01%
37,007
+9,138
+33% +$311K
ALV icon
536
Autoliv
ALV
$9.09B
$1.35M 0.01%
14,493
-24,421
-63% -$2.43M
SJM icon
537
J.M. Smucker
SJM
$13.2B
$1.35M 0.01%
11,108
-150
-1% -$17.7K
ESS icon
538
Essex Property Trust
ESS
$18.9B
$1.34M 0.01%
4,553
+471
+12% +$137K
FWONA icon
539
Liberty Media Series A
FWONA
$23.3B
$1.33M 0.01%
18,582
-930
-5% -$65.3K
CPAY icon
540
Corpay
CPAY
$25.1B
$1.33M 0.01%
4,246
+349
+9% +$103K
CVSA
541
Covista Inc
CVSA
$4.3B
$1.28M 0.01%
17,000
– –
BEN icon
542
Franklin Resources
BEN
$17.3B
$1.28M 0.01%
63,504
+15,318
+32% +$330K
Z icon
543
Zillow
Z
$7.7B
$1.28M 0.01%
19,972
-65,028
-77% -$3.49M
CSGP icon
544
CoStar Group
CSGP
$12.4B
$1.26M 0.01%
16,764
+1,840
+12% +$140K
ALB icon
545
Albemarle
ALB
$13.3B
$1.26M 0.01%
13,300
+352
+3% +$31.2K
COO icon
546
Cooper Companies
COO
$14.1B
$1.25M 0.01%
11,348
– –
BAX icon
547
Baxter International
BAX
$12.6B
$1.25M 0.01%
32,927
+912
+3% +$33.5K
SMPL icon
548
Simply Good Foods
SMPL
$941M
$1.21M 0.01%
34,888
-3,540
-9% -$120K
AIZ icon
549
Assurant
AIZ
$14B
$1.2M 0.01%
6,031
-688
-10% -$125K
LVS icon
550
Las Vegas Sands
LVS
$32B
$1.17M 0.01%
23,256
+2,300
+11% +$94.3K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.